List of Figures
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2018* 8
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Refractory Acute Myeloid Leukemia to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Refractory Acute Myeloid Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Refractory Acute Myeloid Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Refractory Acute Myeloid Leukemia to Oncology Clinical Trials, E7 Countries (%), 2018* 19
Refractory Acute Myeloid Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Refractory Acute Myeloid Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Refractory Acute Myeloid Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 30
GlobalData Methodology 377


List of Tables
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials by Region, 2018* 8
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Refractory Acute Myeloid Leukemia to Oncology Clinical Trials, G7 Countries (%), 2018* 16
Refractory Acute Myeloid Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Refractory Acute Myeloid Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Refractory Acute Myeloid Leukemia to Oncology Clinical Trials, E7 Countries (%), 2018* 19
Refractory Acute Myeloid Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Refractory Acute Myeloid Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials by Phase, 2018* 22
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23
Refractory Acute Myeloid Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Refractory Acute Myeloid Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Refractory Acute Myeloid Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 30